ProfileGDS4718 / 219362_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 88% 86% 83% 88% 87% 83% 85% 89% 83% 87% 90% 85% 88% 81% 82% 87% 87% 84% 85% 83% 88% 89% 86% 88% 87% 84% 85% 82% 86% 84% 87% 82% 86% 89% 79% 79% 85% 87% 86% 86% 89% 85% 77% 84% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.8497688
GSM549102patient 115, normal, homogenized [OPG study]8.548686
GSM549104patient 119, normal, homogenized [OPG study]8.2588483
GSM549108patient 138, normal, homogenized [OPG study]8.7532888
GSM549119patient 077, normal, homogenized [OPG study]8.7708987
GSM549133patient 032, cancer, homogenized [OPG study]8.4006283
GSM549139patient 042, cancer, homogenized [OPG study]8.4438185
GSM549099patient 107, normal, homogenized [OPG study]8.9910289
GSM549109patient 139, normal, homogenized [OPG study]8.1023783
GSM549110patient 046, normal, homogenized [OPG study]8.8000987
GSM549114patient 063, normal, homogenized [OPG study]9.4415890
GSM549122patient 082, normal, homogenized [OPG study]8.5264185
GSM549134patient 033, cancer, homogenized [OPG study]8.8788488
GSM549136patient 036, cancer, homogenized [OPG study]8.0998881
GSM549140patient 044, cancer, homogenized [OPG study]8.1927882
GSM549111patient 047, normal, homogenized [OPG study]8.8112687
GSM549113patient 057, normal, homogenized [OPG study]8.9357987
GSM549132patient 031, cancer, homogenized [OPG study]8.322484
GSM549137patient 038, cancer, homogenized [OPG study]8.4479285
GSM549142patient 047, cancer, homogenized [OPG study]7.8925883
GSM549100patient 110, normal, homogenized [OPG study]8.8237788
GSM549107patient 135, normal, homogenized [OPG study]9.0979489
GSM549115patient 068, normal, homogenized [OPG study]8.7954386
GSM549116patient 072, normal, homogenized [OPG study]9.007388
GSM549120patient 078, normal, homogenized [OPG study]8.8003387
GSM549131patient 030, cancer, homogenized [OPG study]8.4883284
GSM549118patient 074, normal, homogenized [OPG study]8.5120485
GSM549129patient 027, cancer, homogenized [OPG study]8.1436482
GSM549123patient 088, normal, homogenized [OPG study]8.6459286
GSM549124patient 006, cancer, homogenized [OPG study]8.2531384
GSM549126patient 015, cancer, homogenized [OPG study]8.7012387
GSM549128patient 025, cancer, homogenized [OPG study]8.1856582
GSM549103patient 117, normal, homogenized [OPG study]8.4052786
GSM549117patient 073, normal, homogenized [OPG study]9.2138889
GSM549138patient 041, cancer, homogenized [OPG study]7.7773779
GSM549141patient 045, cancer, homogenized [OPG study]7.8654579
GSM549130patient 028, cancer, homogenized [OPG study]8.3474285
GSM549101patient 111, normal, homogenized [OPG study]8.6696887
GSM549105patient 128, normal, homogenized [OPG study]8.5889486
GSM549106patient 134, normal, homogenized [OPG study]8.7856486
GSM549112patient 048, normal, homogenized [OPG study]9.1379789
GSM549125patient 011, cancer, homogenized [OPG study]8.3791285
GSM549127patient 024, cancer, homogenized [OPG study]7.6557477
GSM549135patient 035, cancer, homogenized [OPG study]8.4923384